Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Access expired on Sunday, June 18, 2017

This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.

Already Have An Account? Log in Now

featured
Published in Dermatology

Journal Scan / Research · May 17, 2017

Use of a Noninvasive Two-Gene Molecular Assay for Cutaneous Melanoma and Impact on Biopsy

JAMA Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Dermatology
Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy
JAMA Dermatol 2017 Apr 26;[EPub Ahead of Print], LK Ferris, B Jansen, J Ho, KJ Busam, K Gross, DD Hansen, JP Alsobrook, Z Yao, GL Peck, P Gerami

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading